During an interview at the 2022 American Heart Association Scientific Sessions in Chicago, Michael A. Portman, MD, FAHA, Seattle Children's Hospital addressed how cardiac disease presents in pediatric vs adult patients.
During an interview at the 2022 American Heart Association Scientific Sessions in Chicago, the different types of cardiac diseases that present in pediatric patients vs adult patients were addressed by Michael A. Portman, MD, FAHA, director, Pediatric Cardiovascular Research, Center for Integrative Brain Research, and professor of pediatrics at Seattle Children's Hospital and the University of Washington in Seattle.
Transcript
How do treatments that address cardiac disease in children differ from those given to adult patients?
That's a really good question. The first issue is that children have different types of disease than adults. So in our particular study, we looked at several different types of heart disease. One was something called Kawasaki disease, which affects the coronary arteries and causes giant sacs, called aneurysms, that have a propensity for developing clots. That really doesn't occur in adults.
The second population is a population of patients who have single ventricle anatomy. So instead of 2 pumping chambers of the heart, there's only 1 and you have to do a surgical procedure called a Fontan procedure to assist 1 ventricle in performing the work of both. So those patients are also at high risk for clotting.
Those patients do grow up, they all grew up to be adults, but these are different diseases than adults get, who have, for instance, atrial fibrillation or myocardial infarction or coronary artery sclerosis—they're totally different types of diseases. We do have patients who have heart failure, and that is similar to adults, but treatment for adults is not necessarily the best treatment for children.
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More